NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), Clovis Oncology, Inc. (NASDAQ:CLVS), YRC Worldwide, Inc. (NASDAQ:YRCW), FORTERRA INC (NASDAQ:FRTA), Shenandoah Telecommunications Co (NASDAQ:SHEN), and Basic Energy Services, Inc. (NYSE:BAS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
FOLD DOWNLOAD: http://Fundamental-Markets.com/register/?so=FOLD
CLVS DOWNLOAD: http://Fundamental-Markets.com/register/?so=CLVS
YRCW DOWNLOAD: http://Fundamental-Markets.com/register/?so=YRCW
FRTA DOWNLOAD: http://Fundamental-Markets.com/register/?so=FRTA
SHEN DOWNLOAD: http://Fundamental-Markets.com/register/?so=SHEN
BAS DOWNLOAD: http://Fundamental-Markets.com/register/?so=BAS
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Amicus Therapeutics, Inc. (NASDAQ:FOLD), Clovis Oncology, Inc. (NASDAQ:CLVS), YRC Worldwide, Inc. (NASDAQ:YRCW), FORTERRA INC (NASDAQ:FRTA), Shenandoah Telecommunications Co (NASDAQ:SHEN), and Basic Energy Services, Inc. (NYSE:BAS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 11th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
AMICUS THERAPEUTICS, INC. (FOLD) REPORT OVERVIEW
Amicus Therapeutics' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Amicus Therapeutics reported revenue of $20.60MM vs $10.87MM (up 89.41%) and analysts estimated basic earnings per share -$0.84 vs -$0.69. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Amicus Therapeutics reported revenue of $36.93MM vs $4.96MM (up 644.86%) and analysts estimated basic earnings per share -$1.85 vs -$1.49. Analysts expect earnings to be released on February 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.41. The estimated EPS forecast for the next fiscal year is -$0.86 and is expected to report on February 27th, 2019.
To read the full Amicus Therapeutics, Inc. (FOLD) report, download it here: http://Fundamental-Markets.com/register/?so=FOLD
-----------------------------------------
CLOVIS ONCOLOGY, INC. (CLVS) REPORT OVERVIEW
Clovis Oncology's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Clovis Oncology reported revenue of $22.76MM vs $16.81MM (up 35.41%) and analysts estimated basic earnings per share -$1.71 vs -$1.24. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Clovis Oncology reported revenue of $55.51MM vs $0.08MM (up 71,067.95%) and analysts estimated basic earnings per share -$7.36 vs -$9.07. Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$1.27. The estimated EPS forecast for the next fiscal year is -$5.82 and is expected to report on February 26th, 2019.
To read the full Clovis Oncology, Inc. (CLVS) report, download it here: http://Fundamental-Markets.com/register/?so=CLVS
-----------------------------------------
YRC WORLDWIDE, INC. (YRCW) REPORT OVERVIEW
YRC Worldwide's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, YRC Worldwide reported revenue of $1,303.60MM vs $1,251.20MM (up 4.19%) and analysts estimated basic earnings per share $0.09 vs $0.09 (unchanged). For the twelve months ended December 31st, 2017 vs December 31st, 2016, YRC Worldwide reported revenue of $4,891.00MM vs $4,697.50MM (up 4.12%) and analysts estimated basic earnings per share -$0.33 vs $0.66. Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.44. The estimated EPS forecast for the next fiscal year is $1.00 and is expected to report on January 30th, 2020.
To read the full YRC Worldwide, Inc. (YRCW) report, download it here: http://Fundamental-Markets.com/register/?so=YRCW
-----------------------------------------
FORTERRA INC (FRTA) REPORT OVERVIEW
FORTERRA INC's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, FORTERRA INC reported revenue of $434.51MM vs $444.26MM (down 2.19%) and basic earnings per share $0.09 vs -$0.18. For the twelve months ended December 31st, 2017 vs December 31st, 2016, FORTERRA INC reported revenue of $1,580.41MM vs $1,363.96MM (up 15.87%) and analysts estimated basic earnings per share -$0.03 vs -$0.16. Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.28. The estimated EPS forecast for the next fiscal year is $0.01 and is expected to report on March 6th, 2019.
To read the full FORTERRA INC (FRTA) report, download it here: http://Fundamental-Markets.com/register/?so=FRTA
-----------------------------------------
SHENANDOAH TELECOMMUNICATIONS CO (SHEN) REPORT OVERVIEW
Shenandoah Telecommunications' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Shenandoah Telecommunications reported revenue of $158.73MM vs $151.78MM (up 4.58%) and analysts estimated basic earnings per share $0.31 vs $0.07 (up 342.86%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Shenandoah Telecommunications reported revenue of $611.99MM vs $535.29MM (up 14.33%) and analysts estimated basic earnings per share $1.35 vs -$0.02. Analysts expect earnings to be released on March 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.14. The estimated EPS forecast for the next fiscal year is $1.38 and is expected to report on March 21st, 2019.
To read the full Shenandoah Telecommunications Co (SHEN) report, download it here: http://Fundamental-Markets.com/register/?so=SHEN
-----------------------------------------
BASIC ENERGY SERVICES, INC. (BAS) REPORT OVERVIEW
Basic Energy Services' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Basic Energy Services reported revenue of $246.33MM vs $233.46MM (up 5.51%) and analysts estimated basic earnings per share -$1.03 vs -$0.53. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Basic Energy Services reported revenue of $864.04MM vs $547.50MM (up 57.82%) and analysts estimated basic earnings per share -$3.72 vs -$2.94. Analysts expect earnings to be released on February 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.55. The estimated EPS forecast for the next fiscal year is -$2.37 and is expected to report on February 28th, 2019.
To read the full Basic Energy Services, Inc. (BAS) report, download it here: http://Fundamental-Markets.com/register/?so=BAS
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2019 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.